Pfizer, Voyager Therapeutics ink USD 630 million gene therapy deal
Under the terms of the agreement, Pfizer will have the right to evaluate novel capsids selected for central nervous system and cardiac tropisms from Voyagers TRACER platform and to exercise options...
United States Tseng Cheng Michael Higgins Pfizer Rare Disease Research Unit Meeting Of The American Society Gene Tropism Redirection
Source: medicaldialogues.in